Knowledge hub

Knowledge hub

Drug Discovery

Microscopy image on computer screen with data charts – visualization of AI-ready phenotypic screening in drug discovery
Blog

From Phenotypic Screening to AI-Powered Insight: How to Generate Data to Get the Most from Ardigen phenAID

Illustration of Explainable AI in drug discovery, showing model interpretability and data transparency
Can You Trust Your Model? Why Explainability Matters in AI-Driven Drug Discovery
Learn how biotech can innovate faster and smarter. Discover how AI can benefit biologics’ discovery from protein design to in silico testing.
The AI-Biology Convergence: Designing the Next Generation of Biologics
,
Nature Methods cover image and cell morphology visualization from JUMP Cell Painting study
New publication in Nature Methods: How gene activity shapes cell structure
,
Scientist working in a laboratory environment, symbolizing biotech innovation and AI-driven drug discovery.
New publication: Biologically relevant models and AI increase scalability in CRC drug screening
Scientist analyzing high-content cell images on a computer screen – visualizing AI-driven phenotypic profiling in drug discovery.
The Future of Drug Discovery: Integrating Phenotypic Data with Omics and AI
a biopharma lab
What’s trending in European Biopharma? A look ahead
banner that introduces blog post a key take aways from the Drug Discovery Conference
Data dreams and drug design: What we learned at Discovery and Development Europe 2025
BIO Convention 2025
BIO International Convention 2025 – New Standards in Collaboration, Innovation, and the Integration of AI in Biotechnology
Blog

Biologics 2.0 – From monoclonal antibodies to multispecific therapeutics

High-performance computing servers powering biomedical data pipelines and drug discovery.
Beyond the Petabytes: What It Really Takes to Power the Next Leap in Drug Discovery
Ardigen co-organizes CVPR 2025 workshop on Computer Vision for Drug Discovery
Two scientists observing AI-driven cell analysis on a digital screen, representing decision-making in biotech innovation.
Build or Buy? Strategic Considerations for Biotech Companies Implementing AI Solutions
biotech US market
AI in biotech: What the US market got right (and what it’s still learning)
an Majta presenting on AI and omics data in drug discovery at NextGen Omics Conference 2025.
From Data Chaos to Drug Discovery – Ardigen Talk at NextGen Omics Conference
BioIT 2025 insights
AI, Genomics and the Future of Medicine: Highlights from Bio-IT World Conference & Expo 2025
optimization strategies for scalable bioinformatics workflows.
The Scaling Paradox: Why Adding More Cloud Resources in Bioinformatics Doesn’t Always Solve the Problem
nextgen omics 2025
Insights from NextGen Omics 2025
  • Services
  • Technology
Social Media
United States

611 Gateway Boulevard South San Francisco, CA 94080 USA
tel.+1 628 200 09 14

One Broadway, 14th Floor
Cambridge, MA 02142
USA
tel.+1 628 200 09 14

European Union

Sternbacha 1 30-394 Kraków Poland
tel.+48 12 340 94 94